The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
Feature|Videos|April 20, 2023
Cannabis Science Conference Spring with Dustin Sulak, DO
Author(s)Madeline Colli, Erin McEvoy
Dustin Sulak, DO, founder of Healer and Integr8 Health, served as one of the keynote speakers at Cannabis Science Conference Spring 2023.
Advertisement
Hear Dustin Sulak, DO share details from his presentation, "Low and Ultra-Low Doses of Cannabinoids: Are We Missing the Sweet Spot?" In this interview with Cannabis Science and Technology, Dr. Sulak provides insights into what inspired this presentation and how medical cannabis can help shape healthcare.
Advertisement
Related to this article
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Our top cannabis news topics this week: President Trump’s executive order on cannabis rescheduling, hemp regulation legislation, NY program using cannabis to reduce opioid use, cannabis genetics and cannabinoid profiles, and the latest cannabis research studies.
This month’s webinar explored published research studies on cannabis and its effect on opioids, substance use reduction, alcohol use, and autism symptoms.
President Trump signed an executive order directing federal agencies to reclassify cannabis from Schedule I to Schedule III controlled substances.
Zacariah Hildenbrand, PhD and Adam Jacques discuss how cannabis genetics affect cannabinoids.
A recent study found that medical cannabis may play a role in decreasing opioid use.
The review analyzed more than 2,500 articles, finding inconsistent evidence for certain conditions and an increased risk for harm.
Advertisement
Advertisement